Hims & Hers Health Inc (NYSE:HIMS)
$ 21.435 0.675 (3.25%) Market Cap: 4.64 Bil Enterprise Value: 4.42 Bil PE Ratio: 267.94 PB Ratio: 12.84 GF Score: 54/100

Q4 2023 Hims & Hers Health Inc Earnings Call Transcript

Feb 26, 2024 / 10:00PM GMT
Release Date Price: $10.25 (+7.67%)
Operator

Ladies and gentlemen, thank you for standing by. At this time. I would like to welcome everyone to the Hims & Hers Fourth Quarter and Full Year 2023 earnings conference call. Please note that this call is being recorded. If you would like to ask a question, please press star followed by the number one on your telephone keypad. And if you'd like to withdraw your question again, press star one. Thank you. I would now like to turn today's call over to Bill Newby Director of Investor Relations.

Bill, please go ahead.

Bill Newby
Hims & Hers Health Inc - IR

Good afternoon and everyone. Welcome to the Enzon hers Fourth Quarter and Full Year 2023 earnings call. Today after the market closed we released our first ever shareholder letter, a copy of which you can find on our website, investors dot Enzo.com.

On the call with me today are Andrew Don, our Co-Founder and Chief Executive Officer as well, Jamie Quebec, our Chief Financial Officer.

Before I hand it over to Andrew, I need to remind you of the usual safe harbor and cautionary

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot